Showing results 6 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Surprisingly Promising Tumor Control Rate of S1 Combination with Anlotinib with Refractory Relapsed SCLC Who Failed ≥ 2 Lines Chemotherapy Proceeding/Conference:Journal of Thoracic Oncology | 2019 |